Effects of ebselen on cerebral ischemia and reperfusion evaluated by microdialysis

Neurological Research

Volumn 21, Issue 7, 1999, Pages 682-686

  Kondoh, Susumu ^a   Nagasawa, Shiro ^a   Kawanishi, Masahiro ^a   Yamaguchi, Kazunobu ^a   Kajimoto, Sachiko ^a   Ohta, Tomio ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Cerebral ischemia; Cerebral metabolism; Ebselen; Microdialysis; Reperfusion

Indexed keywords

ADENOSINE; EBSELEN; GLUTATHIONE PEROXIDASE; HYPOXANTHINE; INOSINE; LACTIC ACID; LIPOXYGENASE; PROSTAGLANDIN SYNTHASE; PURINE; PYRUVIC ACID;

ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; BRAIN METABOLISM; BRAIN PROTECTION; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICRODIALYSIS; NONHUMAN; RAT; REPERFUSION;

EID: 0032713912     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1080/01616412.1999.11740998     Document Type: Article

References (32)

1. Sakamoto A, Onishi ST, Onishi T, Ogawa R. Relationship between free radical production and lipid peroxidation during ischemia-reperfusion injury in the rat brain. Brain Res 1991; 554: 186-192
2. Siesjo B, Agardh CD, Bengtsson F. Free radicals and brain damage. Cerebrovasc Brain Metab Rev 1989; 1: 165-211
3. Traystman RJ, Kirsch JR, Koehler RC. Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J Appl Physiol 1991; 71: 1185-1195
4. Zini I, Tomasi A, Grimaldi R, Vannini V, Agnati LF. Detection of free radicals during brain ischemia and reperfusion by spin trapping and microdialysis. Neurosci Lett 1992; 138: 279-282
5. Sies H. Ebselen, a selenoorganic compound as glutathione peroxidase mimic. Free Rad Biol Med 1993; 14: 313-323
6. Wendel A, Fausel M, Safayhi H, Tiegs C, Otter R. A novel biologically active selenoorganic compound. II. Activity of PZ51 in relation to glutathione peroxidase. Biochem Pharmacol 1984; 33: 3241-3245
7. Matui T, Jhoshita H, Asano T, Tnaka J. Effect of a free radical scavenger, ebselen, on cerebral ischemia. In: Krieglstein J, Oberpichler H, eds. Pharmacology of Cerebral Ischemia, Stuttgart: Wissenschaftliche Verlagsgesells chft mbH, 1990: pp. 363-367
8. Dawson DA, Masayasu H, Graham DI, Macrae IM. The neuro-protective efficacy of ebselen (a glutathione peroxidase mimic) in brain damage induced by transient focal cerebral ischaemia in the rat. Neurosci Lett 1995; 185: 65-69
9. Joshita H, Sasaki T, Matui T, Hamamura T, Masayasu H, Asano T, Takakura K. Effects of ebselen (PZ51) on ischaemic brain oedema after focal ischaemia in cat. Acta Neurochir (Wien) 1990; 51: 239-241
10. Takasago T, Peters EE, Graham DI, Masayasu H, Maccae IM. Neuroprotective efficacy of ebselen, an anti-oxidant with anti-inflammatory action, in a rodent model of permanent middle cerebral artery occlusion. Br J Pharmacol 1997; 122: 1251-1256
11. Watanabe T, Nishiyama M, Hori T, Asano T, Shimizu T, Masayasu H. Ebselen (DR3305) ameliorates delayed cerebral vasospasm in a canine two-hemorrhage model. Neurol Res 1997; 19: 563-565
12. Benveniste H. Brain microdialysis. J Neurochem 1989; 52: 1669-1679
13. Pulsinelli WA, Brierley JB. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 1979; 10: 262-272
14. Pelligrino LJ, Pelligrino AS, Cushmann AJ. A Stereotaxic Atlas of the Rat Brain, New York: Plenum Press, 1979
15. Sciotti VM, Van Wylen DGL. Attenuation of ischemia-induced extracellular adenosine accumulation by homocysteine. J Cereb Blood Flow Metab 1993; 13: 208-213
16. Von Wylen DGL, Park TS, Rubio R, Berne RM. Increase in cerebral interstitial fluid adenosine concentration during hypoxia, local potassium infusion, and ischemia. J Cereb Blood Flow Metab 1986; 6: 522-528
17. Wassermann K, Beaver WL, Whipp BJ. Gas exchange theory and the lactic acidosis (anaerobic) threshold. Circulation 1990; 81: 14-30
18. Siesjo BK. Acidosis and ischemic brain damage. Neurochem Pathol 1988; 9: 31-88
19. Rehncrona S, Rosen I, Siesjo BK. Brain lactic acidosis and ischemic cell damage. I. Biochemistry and neurophysiology. J Cereb Blood Flow Metab 1981; 1: 297-311
20. Kalimo H, Rehncrona S, Soderfeldt B, Olsson Y, Siesjo BK. Brain lactic acidosis and ischemic cell damage. II. Histopathology. J Cereb Blood Flow 1981; 1: 313-327
21. Hagberg P, Anderson P, Butcher M, Sandberg M. Extracellular adenosine, inosine, hypoxanthine, xanthine in relation to tissue nucleotides and purine in rat striatum during transient ischemia. J Neurochem 1987; 49: 227-231
22. Hillered L, Hallstrom A, Stegersvard S, Person L, Ungerstedt U. Dynamic changes of extracellular metabolites in the striatum after middle cerebral artery occlusion in the rat monitored by intracerebral microdialysis. J Cereb Blood Flow Metab 1989; 9: 607-616
23. Matsumoto K, Graf R, Rosner G, Shimada N. Flow thresholds for extracellular purine catabolite elevation in cat focal ischemia. Brain Res 1992; 579: 309-314
24. Matsumoto K, Graf R, Rosner G, Taguchi J, Heiss WD. Elevation of neuroactive substances in the cortex of cats during prolonged focal ischemia. J Cereb Blood Flow Metab 1993; 13: 586-594
25. Morimoto K, Tagawa K, Hayakawa T, Watanabe F, Mogami H. Cellular level of purine compounds in ischemic gerbil brain by high performance liquid chromatography. J Neurochem 1982; 38: 833-835
26. Nilsson P, Hillered L, Ponten U, Ungerstedt U. Changes in cortical extracellular levels of energy-related metabolites and amino acids fol lowing concussive brain in rats. J Cereb Blood Flow Metab 1990; 10: 631-637
27. Onodera H, Iijima K, Kogure K. Mononucleotide metabolism in the rat brain after transient ischemia. J Neurochem 1986; 46: 1704-1710
28. Dunviddie TV. The physiological role of adenosine in the central nervous system. Int Rev Neurobiol 1985; 27: 63-159
29. Dragunow M, Goddard GV, Laverty R. Is adenosine an endogenous anticonvulsant? Epilepsia 1985; 26: 480-487
30. Lee KS, Shubert P, Heinemann V. The anticonvulsant action of adenoma: Post-synaptic, dentritic action of a possible endogenous anticonvulsant. Brain Res 1985; 321: 1650-1664
31. Maiorino M, Roveri A, Coassin M, Ursini F. Kinetic mechanism and substrate specificity of glutathione peroxidase activity of ebselen (PZ51). Biochem Pharmacol 1989; 37: 2267-2271
32. Muller A, Cadenas E, Graf P, Sies H. A novel biological active selenoorganic compound. I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ51 (ebselen). Biochem Pharmacol 1984; 33: 3235-3239